On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used as a therapy against SARS-CoV2, the virus that causes COVID-19.

The Company discovered these antibodies through a collaboration with BioBridge Global (parent organization of the South Texas Blood & Tissue Center and QualTex Laboratories, one of the largest independent testing laboratories in the U.S.